Nello Mainolfi, Chief Executive Officer at Kymera Therapeutics, Inc. (KYMR), sold 16,490 shares at $50.05 ($825K) on 2021-05-12, disclosed to the SEC on 2021-05-14.
Open-market sale of $825k KYMR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.05 | 8,245 | $413K | 50.0% |
| 2 | $50.05 | 8,245 | $413K | 50.0% |
| Total | $50.05 avg | 16,490 | $825K | 100% |
| Filing → |
| KYMR | SELL | 2026-07-02 | $9.2M | — | Filing → |
| KYMR | SELL | 2026-04-29 | $2.4M | — | Filing → |
| KYMR | SELL | 2026-02-25 | $2.7M | — | Filing → |